BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lodotra prednisone regulatory update

FDA accepted for review an NDA from Horizon for Lodotra to treat rheumatoid arthritis (RA). The PDUFA date is July 26, 2012. Lodotra uses Geoclock delivery technology from SkyePharma, which is...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >